Paper42499705
Chinese herbal medicine-derived exosome-like nanovesicles for orthopaedic diseases: evidence, methods, and translation.
Zhu YH and 5 others. Front Cell Dev Biol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Chinese herbal medicine-derived exosome-like nanovesicles for orthopaedic diseases: evidence, methods, and translation. Papers, record 42499705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42499705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chinese herbal medicine-derived exosome-like nanovesicles for orthopaedic diseases: evidence, methods, and translation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References79
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34064936 | Botanicals in Postmenopausal Osteoporosis. | Nutrients | 2021 | https://conductscience.org/library/papers/34064936 | PubMed |
| 2 | 37107317 | Potential of Plant Exosome Vesicles from Grapefruit (Citrus × paradisi) and Tomato (Solanum lycopersicum) Juices as Functional Ingredients and Targeted Drug Delivery Vehicles. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37107317 | PubMed |
| 3 | 37844380 | Aloe vera peel-derived nanovesicles display anti-inflammatory properties and prevent myofibroblast differentiation. | Phytomedicine | 2024 | https://conductscience.org/library/papers/37844380 | PubMed |
| 4 | 38263267 | The role and applications of extracellular vesicles in osteoporosis. | Bone Res | 2024 | https://conductscience.org/library/papers/38263267 | PubMed |
| 5 | 38704110 | Advances in the study of plant-derived extracellular vesicles in the skeletal muscle system. | Pharmacol Res | 2024 | https://conductscience.org/library/papers/38704110 | PubMed |
| 6 | 37984307 | Plant-derived extracellular vesicles -a novel clinical anti-inflammatory drug carrier worthy of investigation. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37984307 | PubMed |
| 7 | 38828203 | Unlocking the Medicinal Potential of Plant-Derived Extracellular Vesicles: current Progress and Future Perspectives. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/38828203 | PubMed |
| 8 | 39036078 | Plant-derived exosomes extracted from Lycium barbarum L. loaded with isoliquiritigenin to promote spinal cord injury repair based on 3D printed bionic scaffold. | Bioeng Transl Med | 2024 | https://conductscience.org/library/papers/39036078 | PubMed |
| 9 | 35214189 | Stability of Plant Leaf-Derived Extracellular Vesicles According to Preservative and Storage Temperature. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35214189 | PubMed |
| 10 | 38959219 | Isolation and characterization of plant-derived exosome-like nanoparticles from Carica papaya L. fruit and their potential as anti-inflammatory agent. | PLoS One | 2024 | https://conductscience.org/library/papers/38959219 | PubMed |
| 11 | 36519808 | Plant-derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications. | J Extracell Vesicles | 2022 | https://conductscience.org/library/papers/36519808 | PubMed |
| 12 | 34990792 | Technology insight: Plant-derived vesicles-How far from the clinical biotherapeutics and therapeutic drug carriers? | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/34990792 | PubMed |
| 13 | 38890638 | Cartilage progenitor cells derived extracellular vesicles-based cell-free strategy for osteoarthritis treatment by efficient inflammation inhibition and extracellular matrix homeostasis restoration. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/38890638 | PubMed |
| 14 | 36037973 | Plant-derived extracellular vesicles as oral drug delivery carriers. | J Control Release | 2022 | https://conductscience.org/library/papers/36037973 | PubMed |
| 15 | 40749757 | Extracellular vesicles: A new frontier in deciphering the mechanisms of traditional Chinese medicine. | Pharmacol Res | 2025 | https://conductscience.org/library/papers/40749757 | PubMed |
| 16 | 40867539 | A New Perspective on Regenerative Medicine: Plant-Derived Extracellular Vesicles. | Biomolecules | 2025 | https://conductscience.org/library/papers/40867539 | PubMed |
| 17 | 35448322 | Plant-RNA in Extracellular Vesicles: The Secret of Cross-Kingdom Communication. | Membranes (Basel) | 2022 | https://conductscience.org/library/papers/35448322 | PubMed |
| 18 | 36978093 | Plant-derived extracellular vesicles (PDEVs) in nanomedicine for human disease and therapeutic modalities. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/36978093 | PubMed |
| 19 | 37984504 | Therapeutic potential of plant-derived extracellular vesicles as nanocarriers for exogenous miRNAs. | Pharmacol Res | 2023 | https://conductscience.org/library/papers/37984504 | PubMed |
| 20 | 39634409 | Revolutionizing medicine: Harnessing plant-derived vesicles for therapy and drug transport. | Heliyon | 2024 | https://conductscience.org/library/papers/39634409 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42865716 | Roles of exosomal miRNAs from different sources in knee osteoarthritis: exercise-regulated skeletal muscle-derived exosomal miRNAs as a prospective therapeutic avenue. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42865716 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42499705
GET https://conductscience.org/api/papers/v1/42499705/references?page=2